top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Diabetic Neuropathy


Non-Pharmacological Management

  • Foot Care:

    • Wear well-fitting footwear

    • Perform daily self-examination of feet for wounds, blisters, or skin changes

    • Regular podiatry reviews

    • Refer to high-risk foot clinic if necessary

    • Refer to vascular surgeon for advanced complications

  • Optimise Systemic Health:

    • Achieve good glycaemic control

    • Manage cardiovascular risk factors (e.g., smoking cessation, blood pressure, lipids)

____________________________________


Pharmacological Management

  • 1st-line Meds for Painful Neuropathy may either be:

    • Amitriptyline: 25 mg at night (titrated up to 150 mg nocte if tolerated)

    • Duloxetine: 60 mg daily (max 120 mg/day)

    • Pregabalin: 75 mg twice daily (titrate up to 300 mg bd)

    • Gabapentin: Start at 300 mg daily (max 1200 mg tid)

  • Adjuncts:

    • Topical capsaicin cream (if oral medications are not tolerated)

Note

  • Titrate medications gradually to minimise SEs. Lower starting doses for elderly patients.

  • Topical nitrate spray (not on eTG but on racgp T2DM handbook) 

____________________________________


Important Considerations

  • Screen for other causes of neuropathy (e.g., vitamin B12 deficiency, hypothyroidism)

  • Patients with loss of protective sensation (e.g., insensate neuropathy) are at high risk for foot ulcers and Charcot arthropathy

  • Regular foot assessments can prevent complications​

  • Differentials for general and unilateral neuropathy

____________________________________


Differentials for general neuropathy


  • Diabetic neuropathy

  • Prolonged excessive alcohol use

  • Peripheral arterial disease

  • B12 deficiency

  • Hypothyroidism

  • Chronic kidney disease (peripheral oedema, change in urinary frequency)

  • Multiple myeloma

  • Idiopathic (25%)

  • Restless legs syndrome (strong urge to move legs)

  • Raynauds phenomenon

____________________________________


Differentials for unilateral neuropathy


  • L5/S1 nerve root compression (shooting pain from the back)

  • Chronic regional pain syndrome (recent trauma to the limb)

  • Mortons neuroma (worse with tight shoes)

  • Tarsal tunnel syndrome (PT nerve (medial))

____________________________________


Hallmark and Atypical Symptoms

  • Classic symptoms:

    • Numbness, tingling, or burning pain starting in the toes and progressing proximally (stocking-glove distribution)

    • Symmetrical and slow progression

    • Sensory loss that can coexist with pain (e.g., "painful insensate foot")

  • Atypical features:

    • Sudden or asymmetrical onset (e.g., diabetic amyotrophy or mononeuropathies)

    • Involvement of proximal muscles, such as pelvic or thigh girdle weakness (diabetic radiculoplexus neuropathy)​

____________________________________


History

  • Typical symptoms:

    • Burning, aching pain and paraesthesia

    • Numbness or reduced sensation

    • Difficulty with balance, especially in the dark

  • Assess risk factors:

    • Poor glycaemic control

    • History of smoking, hypertension, or dyslipidaemia (risk factors for peripheral arterial disease)

    • Past foot ulcers or Charcot foot​

____________________________________


Features of Examination for Peripheral Neuropathy

  • Neurological assessment:

    • Loss of protective sensation (e.g., absent 10 g monofilament response)

    • Reduced vibration perception (e.g., using a 128 Hz tuning fork)

    • Reduced ankle reflexes

    • Loss of pinprick or temperature sensation

  • MSK assessment:

    • Deformities such as claw toes, prominent metatarsal heads, or collapsed arches (Charcot foot features)

  • Other findings:

    • Signs of neuropathic ulceration or infection

    • Reduced peripheral pulses (if concomitant peripheral arterial disease is present)​

____________________________________


Notes

  • Screening:

    • Routine annual screening is essential, even in asymptomatic patients, as neuropathy increases the risk of foot ulcers and amputations.

  • Prevention and Management:

    • Optimise glycaemic control to slow progression but note that established neuropathy is irreversible.

    • Address risk factors (e.g., smoking cessation, blood pressure, and lipid management).

    • Pain management options include amitriptyline, duloxetine, gabapentin, or pregabalin, titrated to response​

Bookmark Failed!

Bookmark Saved!

bottom of page